Lisa M. Kaminskas

Pulmonary administration of a doxorubicin-conjugated dendrimer enhances drug exposure to lung metastases and improves cancer therapy

Lisa M. Kaminskas, Victoria M. McLeod, Gemma M. Ryan et al. · Journal of Controlled Release · 2014 · 187 citations

Cancer Therapy, Lung Metastases, Oncology +10

The Impact of Molecular Weight and PEG Chain Length on the Systemic Pharmacokinetics of PEGylated Poly <scp>l</scp>-Lysine Dendrimers

Lisa M. Kaminskas, Ben J. Boyd, Peter Karellas et al. · Molecular Pharmaceutics · 2008 · 174 citations

Pharmaceutical Science, Engineering, Systemic Pharmacokinetics +16

A comparison of changes to doxorubicin pharmacokinetics, antitumor activity, and toxicity mediated by PEGylated dendrimer and PEGylated liposome drug delivery systems

Lisa M. Kaminskas, Victoria M. McLeod, Brian D. Kelly et al. · Nanomedicine Nanotechnology Biology and Medicine · 2011 · 168 citations

Nanomedicine, Antitumor Activity, Polymer-drug Conjugate +9

Cationic Poly- <scp>l</scp> -lysine Dendrimers:  Pharmacokinetics, Biodistribution, and Evidence for Metabolism and Bioresorption after Intravenous Administration to Rats

Ben J. Boyd, Lisa M. Kaminskas, Peter Karellas et al. · Molecular Pharmaceutics · 2006 · 159 citations

PEGylation of polylysine dendrimers improves absorption and lymphatic targeting following SC administration in rats

Lisa M. Kaminskas, Jagannath Kota, Victoria M. McLeod et al. · Journal of Controlled Release · 2009 · 144 citations

Sc Administration, Pharmaceutical Science, Drug Targeting +7